logo

For the Inventor, By the Inventor

New Providence, NJ, United States of America

Anthony J Tutino

This inventor holds 7 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Celgene Corporation, Signal Pharmaceuticals, Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony J Tutino. Retrieved from https://idiyas.com/inventor/anthony-j-tutino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:

goldMedal5 out of 561 
 
Celgene Corporation
 patents
silverMedal2 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents

Years Active: 2013-2020

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 10555939 - Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione (2020-02-11),
2. 9993467 - Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione (2018-06-12),
3. 9468605 - Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione (2016-10-18),
4. 9393255 - Pharmaceutical compositions of cytidine analogs and methods of use thereof (2016-07-19),
5. 9198866 - Pharmaceutical formulations of a substituted diaminopurine (2015-12-01),
6. 8828427 - Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione (2014-09-09),
7. 8603527 - Pharmaceutical formulations of a substituted diaminopurine (2013-12-10),

Title: The Innovative Contributions of Anthony J Tutino

Introduction

Anthony J Tutino is a notable inventor based in New Providence, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on developing formulations that address various medical conditions, including cancer and inflammatory diseases.

Latest Patents

Among his latest patents are formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione. These patents include pharmaceutical compositions and single unit dosage forms of this compound, or its pharmaceutically acceptable stereoisomers, prodrugs, salts, solvates, hydrates, or clathrates. The patents also detail methods for treating, managing, or preventing various disorders, such as cancer or inflammatory diseases.

Career Highlights

Anthony has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Signal Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop innovative solutions that contribute to advancements in medical treatments.

Collaborations

Throughout his career, Anthony has collaborated with esteemed colleagues, including Michael T Kelly and Sreenivas S Bhat. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Anthony J Tutino's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in the treatment of serious medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…